August 14, 2012
2 min read

Type 2 diabetes duration associated with disease recurrence after gastric bypass

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Data from a retrospective analysis of patients who underwent Roux-en-Y gastric bypass surgery at the Mayo Clinic Arizona demonstrate that the rate of type 2 diabetes recurrence after the procedure was 21%. Additionally, duration of diabetes was linked to rate of recurrence after surgery.

“Patients with more than 5 years of type 2 diabetes prior to bariatric surgery were 3.8 times more likely to develop a recurrence of type 2 diabetes,” Yessica Ramos, MD, an internal medicine resident at Mayo Clinic Arizona in Scottsdale, said during a press conference.

The researchers identified 138 patients who underwent Roux-en-Y gastric bypass surgery between January 2000 and December 2007. Of these, 72 were included in their analysis and had a minimum of 3 years of continuous follow-up.

Ramos and colleagues aimed to determine the persistence, remission and re-emergence of type 2 diabetes after surgery. Remission was defined as HbA1c <6.5% with no pharmacological treatment; re-emergence was defined as HbA1c ≥6.5%, fasting glucose >7mmol/L or re-initiation of antidiabetic medications, according to the abstract.

Most patients (93%) were white, with a mean age of 49.5 years, and 54% were female. Preoperatively, mean BMI was 45 and mean duration of type 2 diabetes was 4.9 years.

There were 66 patients in remission at a minimum of one time point, and six patients had persistent type 2 diabetes throughout follow-up. Of the 66 patients, 14 had recurrent type 2 diabetes: five patients developed disease 2 years after surgery, three at 3 years after, three at 4 years after and three at 5 years after. Additionally, duration of type 2 diabetes before Roux-en-Y surgery was significantly related to recurrence of disease (P=.0021).

“We ended up finding that one-fifth of the patients will develop diabetes after at least 3 years of follow-up, and up to 5 years of follow-up,” Ramos said.

The most relevant finding was that “the association included a long-standing history of diabetes,” she added.

The OR demonstrating that longer duration of preoperative type 2 diabetes was linked with a higher probability of recurrence was 3.81 after adjusting for time (>5 years vs. <5 years of diabetes). According to Ramos, there was no significant association between preoperative BMI or weight regain and a higher recurrence rate.

“Our conclusions were that the length of diabetes prior to bariatric surgery had a strong relationship to the re-emergence rate of diabetes. Early surgical intervention with type 2 diabetes patients who are obese may improve the durability of their remission of diabetes,” Ramos said.

Ramos Y. Abstract #SAT-161.

Disclosure: The researchers report no relevant financial disclosures.